ADAR1 isoform involvement in embryonic lethality
Letters to the editor recently published in PNAS (1, 2) challenged and defended a claim made on a recent article (3). Matthaei et al. (1) questioned whether the animal model used by Ward et al. (3) was adequate to support their claim that the P150 isoform of the RNA editing enzyme adenosine deaminase 1 (ADAR1) is required for embryogenesis. We believe the question remains open and present data indicating that a more complete assessment of ADAR1 isoform protein expression in the model of Ward et al. (3) is necessary to draw firm conclusions from it.
In mammalian cells, the two major isoforms of ADAR1, P150 and P110, are produced as a result of alternative use of the first exons. P150, arising from exon 1A, contains a Z-DNA binding domain, three RNA binding motifs, and a catalytic editing domain. The P110 isoform lacks the Z-DNA binding domain and is transcribed from exon 1B, which is located upstream of exon 1A. Ward et al. (3) specifically knocked out the P150 isoform through substitution of exon 1A with an antisense-directed PGKneo cassette, while leaving the upstream promoter and exon 1B intact. It is not known whether the PGK promoter was capable of driving antisense ADAR1 transcription from the upstream exon 1B and affected ADAR1 P110 protein translation. Ward et.al. We have examined the expression of ADAR1 in mouse embryos from embryonic days 9 to 11 and confirm the predominance of the P110 isoform and the absence of both P150 and P110 isoforms from ADAR1 −/− mice we prepared previously (4) (Fig. 1A) ; this phenotype is sustained in the fibroblasts derived from the mouse embryos (Fig. 1B) . We also note that the P110 isoform is generated when knockout cells are reconstituted with a P150 cDNA expression vector. This raises the possibility that a cryptic internal ribosome entry site-like sequence within the P150 transcript provides an alternative route for P110 generation. Even specific knockout of P150 may be associated with a decrease in P110 level. In the absence of definitive assessment of P110 protein expression in the P150 −/− embryos and the derived cells, it cannot be conclusively assumed that P110 expression is sustained at wild-type levels and that P110 is noncontributory to the lethal phenotype reported by Ward et al. (3) . 
